PanGenomic develops a health-tech platform to provide personal control over mental health treatments. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's unique user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. Its digital therapeutics clinic platform, the PlantGx Platform, provides health practitioners with access to a consumer's Nara App data. The company was founded in 2015 and is based in Vancouver, Canada.

Butterflly is a digital therapeutics company focused on safe, evidenced-based, highly personalized, and de-stigmatized behavioral health. Users leverage person-generated data and the therapeutic power of peer groups inside secure social media-style private networks. Extended services also include coaching and telehealth therapy.

Our mission is to transform the healthcare space with accessible wellness solutions powered by science, and the latest innovations in tech. Through our proprietary apps and platforms, we empower users to take control of their own wellbeing, and overcome long-standing barriers to mental and physical health. We believe that conventional and holistic medicine can (and should) be complementary — and that the key to better long-term outcomes is a holistic, whole-body approach to healing and wellness.

We deliver culturally-centered, intersectional and evidence-based care for teens and adults from all walks of life while also providing an alternative to in-person therapy that is more affordable and accessible.